[1]
“INFLUENCE EARNINGS PER SHARE , PRICE TO BOOK VALUE, DEBT TO EQUITY RATIO, DIVIDEND PAYOUT RATIO AND CAPITAL WORK TO PRICE SHARES IN PHARMACY COMPANIES”, jit, vol. 17, no. 4, pp. 1078–1084, Dec. 2023, doi: 10.22216/jit.v17i4.2800.